Dr. Perlman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4800 Sand Point Way NE
Seattle, WA 98105Phone+1 206-987-2000Fax+1 206-985-3114
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Neuromuscular Medicine (Neurology), 2012 - 2013- Washington University/B-JH/SLCH ConsortiumFellowship, Child Neurology, 2008 - 2011
- Washington University/B-JH/SLCH ConsortiumResidency, Pediatrics, 2006 - 2008
Rush Medical College of Rush University Medical CenterClass of 2006
Certifications & Licensure
MT State Medical License 2021 - 2025
OR State Medical License 2021 - 2025
WA State Medical License 2019 - 2025
AK State Medical License 2021 - 2024
ID State Medical License 2021 - 2024
IA State Medical License 2013 - 2019
MO State Medical License 2011 - 2014- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
- American Board of Electrodiagnostic MedicineElectrodiagnostic Medicine
Clinical Trials
- Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy Start of enrollment: 2017 Jul 06
- Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA) Start of enrollment: 2018 Sep 25
Publications & Presentations
PubMed
- Clinical RNA sequencing clarifies variants of uncertain significance identified by prior testing.Jonathan Marquez, Jennifer N Cech, Cate R Paschal, Bri Dingmann, Anna I Scott
Genetics in Medicine Open. 2024-01-01 - 1 citationsInpatient rehabilitation admission for a patient with spinal muscular atrophy status post gene therapy.Jaclyn C Omura, Casey L Freeman, Seth J Perlman, Molly M Fuentes
PM & R. 2023-10-01 - 35 citationsEfficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.Michela Guglieri, Paula R Clemens, Seth J Perlman, Edward C Smith, Iain Horrocks
JAMA Neurology. 2022-10-01
Press Mentions
An Autosomal Dominant Neurological Disorder Caused by De Novo Variants in FAR1 Resulting in Uncontrolled Synthesis of Ether LipidsNovember 26th, 2020
Professional Memberships
- Member
- Member
- Child Neurology SocietyMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
